DTRE vs. THNR ETF Comparison

Comparison of First Trust Alerian Disruptive Technology Real Estate ETF (DTRE) to Amplify Weight Loss Drug & Treatment ETF (THNR)
DTRE

First Trust Alerian Disruptive Technology Real Estate ETF

DTRE Description

First Trust Alerian Disruptive Technology Real Estate ETF is an exchange traded fund launched and managed by First Trust Advisors LP. The fund invests in public equity markets. It invests in stocks of companies operating across real estate sectors. It invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the Alerian Disruptive Technology Real Estate Index, by using full replication technique. First Trust Alerian Disruptive Technology Real Estate ETF was formed on August 27, 2007 and is domiciled in the United States.

Grade (RS Rating)

Last Trade

$38.47

Average Daily Volume

1,355

Number of Holdings *

9

* may have additional holdings in another (foreign) market
THNR

Amplify Weight Loss Drug & Treatment ETF

THNR Description The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$26.27

Average Daily Volume

10,610

Number of Holdings *

7

* may have additional holdings in another (foreign) market
Performance
Period DTRE THNR
30 Days -0.16% 2.35%
60 Days 4.34%
90 Days -3.29%
12 Months -3.43%
0 Overlapping Holdings
Symbol Grade Weight in DTRE Weight in THNR Overlap
Compare ETFs